A Randomized Double-Blind, Parallel Group Study Comparing Olanzapine (Zyprexa) With Haloperidol (Novo-Peridol) for the Relief of Nausea and Vomiting in Patients With Advanced Cancer.

Trial Profile

A Randomized Double-Blind, Parallel Group Study Comparing Olanzapine (Zyprexa) With Haloperidol (Novo-Peridol) for the Relief of Nausea and Vomiting in Patients With Advanced Cancer.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 07 Jul 2015

At a glance

  • Drugs Olanzapine (Primary) ; Haloperidol
  • Indications Nausea and vomiting
  • Focus Therapeutic Use
  • Acronyms OHN-1
  • Most Recent Events

    • 18 Jan 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 23 Mar 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top